Reference : Cellular immunotherapy in multiple myeloma : lessons from preclinical models
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/172758
Cellular immunotherapy in multiple myeloma : lessons from preclinical models
English
Binsfeld, Marilène mailto [Université de Liège - ULiège > > GIGA-R : Hématologie >]
Fostier, K. []
Muller, Joséphine [Université de Liège - ULiège > > GIGA-R : Hématologie >]
Baron, Frédéric mailto [Université de Liège - ULiège > > GIGA-R : Hématologie >]
Schots, R. []
Beguin, Yves mailto [Université de Liège - ULiège > > GIGA-R : Hématologie >]
Heusschen, Roy [Université de Liège - ULiège > > GIGA-R : Hématologie >]
CAERS, Jo mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
2014
Biochimica et Biophysica Acta - Reviews on Cancer
Elsevier Science
1846
392-404
Yes (verified by ORBi)
International
0304-419X
[en] multiple myeloma ; mouse models ; immunotherapy ; transplantation ; adoptive transfer ; vaccination
[en] The majority of multiple myeloma patients relapse with the current treatment strategies, raising the need for alternative therapeutic approaches. Cellular immunotherapy is a rapidly evolving field and currently being translated into clinical trials with encouraging results in several cancer types, including multiple myeloma. Murine multiple myeloma models are of critical importance for the development and refinement of cellular immunotherapy. In this review,we summarize the immune cell changes that occur inmultiplemyelomapatients and we discuss the cell-based immunotherapies that have been tested in multiple myeloma, with a focus on murine models.
http://hdl.handle.net/2268/172758

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
329.pdfPublisher postprint736.14 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.